Extension of Indication for Authorised Oncology Products in the European Union: A Joint Effort of Multiple Stakeholders

After marketing authorisation, the development of a medicinal product often continues with studies investigating new therapeutic indications. Positive results can potentially lead to changes to the terms of the marketing authorisation, such as an extension of therapeutic indication(s). These studies...

Descripción completa

Detalles Bibliográficos
Autores principales: Mulder, Jorn, Verjans, Robin, Verbaanderd, Ciska, Pean, Elias, Weemers, Just, Leufkens, Hubert G. M., Pignatti, Francesco, de Boer, Anthonius, Voest, Emile E., Stoyanova-Beninska, Violeta V., Pasmooij, Anna M. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695872/
https://www.ncbi.nlm.nih.gov/pubmed/34957158
http://dx.doi.org/10.3389/fmed.2021.790782

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8695872/
https://www.ncbi.nlm.nih.gov/pubmed/34957158
http://dx.doi.org/10.3389/fmed.2021.790782

Ejemplares similares